Month: May 2014
Mickelson plays on amid news of U.S. probe into possible insider trading
(Adds more Mickelson comments) By Ben Everill DUBLIN, Ohio, May 31 (Reuters) – If golf star Phil Mickelson is concerned by a federal probe into possible insider trading involving him, billionaire investor Carl Icahn and Las Vegas gambler William Walters, he did not show it on Saturday. As he hit a few practice balls before his round at the Memorial Tournament in Dublin, Ohio, Mickelson was in a light-hearted exchange with fellow American golfer Robert Garrigus. “It’s been an interesting evening,” Mickelson replied, adding with a laugh, “I don’t have much to say about it.” Garrigus jokingly intimated that talking with Mickelson could get him into trouble, saying he was “not sure I want to talk to you now.” On Friday night, a source familiar with the matter said the FBI and the U.S. Securities and Exchange Commission were investigating possible insider trading involving Icahn, Mickelson and Walters.
Pharmacyclics, J&J drug shown to improve leukemia survival
By Deena Beasley CHICAGO (Reuters) – A new drug for the most common form of leukemia in adults improves survival for patients whose disease has worsened despite standard treatment, according to late-stage study findings released on Saturday. Ibrutinib, sold by Pharmacyclics Inc and Johnson & Johnson under the brand name Imbruvica, was approved by U.S. regulators for treatment of chronic lymphocytic leukemia in February. The therapy “beat the pants off” of ofatumumab, or Arzerra, marketed by GlaxoSmithKline Plc, in the Phase 3 trial, said Dr. John Byrd, the study’s lead investigator and a professor of medicine at the Ohio State University Comprehensive Cancer Center in Columbus, Ohio. JP Morgan analyst Cory Kasimov said the trial results, along with the fact that the drug is a pill that does not need to be combined with another therapy, could help propel sales.
Watch: Doctor Rushed Into Emergency Surgery Finds Out Patient Is His Mentor
Obama’s boldest move on carbon comes with perils
Warnings on ‘gaming’ patient waits go back years
WASHINGTON (AP) — The report this week confirming that 1,700 veterans were "at risk of being lost or forgotten" at a Phoenix hospital was hardly the first independent review that documented long wait times for some patients seeking health care from the Department of Veterans Affairs and inaccurate records that understated the depth of the problem.